Lv11
40 积分 2022-11-21 加入
Pancreatic cancer
5小时前
待确认
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
3个月前
已完结
Real-World Genomic Profile of EGFR Second-Site Mutations and Other Osimertinib Resistance Mechanisms and Clinical Landscape of NSCLC Post-Osimertinib
3个月前
已完结
MET-dependent solid tumours — molecular diagnosis and targeted therapy
3个月前
已完结
C-MET inhibitors for advanced non-small cell lung cancer
4个月前
已完结
In vivo, ex vivo and in vitro assessment of buccal permeation of drugs from delivery systems
6个月前
已完结
Development of a buccal in vitro permeation method – exploring aQbD implementation
6个月前
已完结
Types and evaluation of in vitro penetration models for buccal mucosal delivery
6个月前
已完结
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer
7个月前
已完结
皖公网安备34019202002308
